ArticleCancer immunology, immunotherapy : CII2011
Primed tumor-reactive multifunctional CD62L+ human CD8+ T cells for immunotherapy.
Matthias Wölfl et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papertrialcites it